rofecoxib has been researched along with Angina at Rest in 5 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " cerebral infarction, myocardial infarction and unstable angina pectoris, among rofecoxib and naproxen users in comparison to diclofenac users." | 3.76 | Rofecoxib, but not celecoxib, increases the risk of thromboembolic cardiovascular events in young adults-a nationwide registry-based study. ( Einarsdottir, R; Gudbjornsson, B; Halldorsson, M; Johannsson, M; Sigvaldason, H; Thorgeirsson, G; Thorsteinsson, SB; Zoega, H, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gudbjornsson, B | 1 |
| Thorsteinsson, SB | 1 |
| Sigvaldason, H | 1 |
| Einarsdottir, R | 1 |
| Johannsson, M | 1 |
| Zoega, H | 1 |
| Halldorsson, M | 1 |
| Thorgeirsson, G | 1 |
| Monakier, D | 1 |
| Mates, M | 1 |
| Klutstein, MW | 1 |
| Balkin, JA | 1 |
| Rudensky, B | 1 |
| Meerkin, D | 1 |
| Tzivoni, D | 1 |
| Chyrchel, M | 1 |
| Dudek, D | 1 |
| BartuĊ, S | 1 |
| Legutko, J | 1 |
| Heba, G | 1 |
| Dubiel, JS | 1 |
| Lekakis, JP | 1 |
| Vamvakou, G | 1 |
| Andreadou, I | 1 |
| Ganiatsos, G | 1 |
| Karatzis, E | 1 |
| Protogerou, A | 1 |
| Papaioannou, T | 1 |
| Ikonomidis, I | 1 |
| Papamichael, C | 1 |
| Mavrikakis, ME | 1 |
| Lee, YH | 1 |
| Ji, JD | 1 |
| Song, GG | 1 |
4 trials available for rofecoxib and Angina at Rest
| Article | Year |
|---|---|
Rofecoxib, a COX-2 inhibitor, lowers C-reactive protein and interleukin-6 levels in patients with acute coronary syndromes.
Topics: Acute Disease; Angina, Unstable; C-Reactive Protein; Coronary Disease; Cyclooxygenase Inhibitors; Do | 2004 |
High-dose statin and COX-2 inhibitor therapy rapidly decreases C-reactive protein level in patients with unstable angina.
Topics: Aged; Angina, Unstable; Angioplasty, Balloon, Coronary; Atorvastatin; C-Reactive Protein; Coronary A | 2004 |
Divergent effects of rofecoxib on endothelial function and inflammation in acute coronary syndromes.
Topics: Acute Disease; Adult; Aged; Angina, Unstable; C-Reactive Protein; Cyclooxygenase 2 Inhibitors; Doubl | 2006 |
Adjusted indirect comparison of celecoxib versus rofecoxib on cardiovascular risk.
Topics: Adenoma; Adenomatous Polyps; Angina, Unstable; Celecoxib; Cyclooxygenase Inhibitors; Humans; Lactone | 2007 |
1 other study available for rofecoxib and Angina at Rest
| Article | Year |
|---|---|
Rofecoxib, but not celecoxib, increases the risk of thromboembolic cardiovascular events in young adults-a nationwide registry-based study.
Topics: Angina, Unstable; Celecoxib; Cerebral Infarction; Cyclooxygenase 2 Inhibitors; Databases, Factual; D | 2010 |